Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000457946 | SCV000554982 | likely benign | Neurofibromatosis, type 1 | 2024-06-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002319008 | SCV001177277 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2018-06-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV001016331 | SCV002527473 | likely benign | Hereditary cancer-predisposing syndrome | 2022-02-07 | criteria provided, single submitter | curation | |
Genome- |
RCV000457946 | SCV002560609 | likely benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing |